410 related articles for article (PubMed ID: 24910453)
21. Impact of preoperative BRCA1/2 testing on surgical decision making in patients with newly diagnosed breast cancer.
Yadav S; Jinna S; Pereira-Rodrigues O; Reeves A; Campian S; Sufka A; Zakalik D
Breast J; 2018 Jul; 24(4):541-548. PubMed ID: 29498445
[TBL] [Abstract][Full Text] [Related]
22. Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.
Schmeler KM; Sun CC; Bodurka DC; White KG; Soliman PT; Uyei AR; Erlichman JL; Arun BK; Daniels MS; Rimes SA; Peterson SK; Slomovitz BM; Milam MR; Gershenson DM; Lu KH
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):515-20. PubMed ID: 16946209
[TBL] [Abstract][Full Text] [Related]
23. Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.
Rosenberg SM; Sepucha K; Ruddy KJ; Tamimi RM; Gelber S; Meyer ME; Schapira L; Come SE; Borges VF; Golshan M; Winer EP; Partridge AH
Ann Surg Oncol; 2015 Nov; 22(12):3809-15. PubMed ID: 25930247
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer treatment in mutation carriers: surgical treatment.
Biglia N; D'Alonzo M; Sgro LG; Tomasi Cont N; Bounous V; Robba E
Minerva Ginecol; 2016 Oct; 68(5):548-56. PubMed ID: 26822896
[TBL] [Abstract][Full Text] [Related]
25. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
[TBL] [Abstract][Full Text] [Related]
26. Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab).
Kiely BE; Jenkins MA; McKinley JM; Friedlander ML; Weideman P; Milne RL; McLachlan SA; Hopper JL; Phillips KA
Breast Cancer Res Treat; 2010 Apr; 120(3):715-23. PubMed ID: 19669874
[TBL] [Abstract][Full Text] [Related]
27. Does mainstream BRCA testing affect surgical decision-making in newly-diagnosed breast cancer patients?
Ain Q; Richardson C; Mutebi M; George A; Kemp Z; Rusby JE
Breast; 2023 Feb; 67():30-35. PubMed ID: 36577271
[TBL] [Abstract][Full Text] [Related]
28. Decision-making process of women carrying a BRCA1 or BRCA2 mutation who have chosen prophylactic mastectomy.
McQuirter M; Castiglia LL; Loiselle CG; Wong N
Oncol Nurs Forum; 2010 May; 37(3):313-20. PubMed ID: 20439215
[TBL] [Abstract][Full Text] [Related]
29. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
Adem C; Reynolds C; Soderberg CL; Slezak JM; McDonnell SK; Sebo TJ; Schaid DJ; Myers JL; Sellers TA; Hartmann LC; Jenkins RB
Cancer; 2003 Jan; 97(1):1-11. PubMed ID: 12491499
[TBL] [Abstract][Full Text] [Related]
30. Twenty-one-gene recurrence score assay in BRCA-associated versus sporadic breast cancers: Differences based on germline mutation status.
Shah PD; Patil S; Dickler MN; Offit K; Hudis CA; Robson ME
Cancer; 2016 Apr; 122(8):1178-84. PubMed ID: 26859126
[TBL] [Abstract][Full Text] [Related]
31. Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?
McGee J; Giannakeas V; Karlan B; Lubinski J; Gronwald J; Rosen B; McLaughlin J; Risch H; Sun P; Foulkes WD; Neuhausen SL; Kotsopoulos J; Narod SA;
Gynecol Oncol; 2017 May; 145(2):346-351. PubMed ID: 28314588
[TBL] [Abstract][Full Text] [Related]
32. Uptake of risk-reducing surgery in BRCA gene carriers in Wales, UK.
Long J; Evans TG; Bailey D; Lewis MH; Gower-Thomas K; Murray A
Breast J; 2018 Jul; 24(4):580-585. PubMed ID: 29286205
[TBL] [Abstract][Full Text] [Related]
33. Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis.
Weitzel JN; McCaffrey SM; Nedelcu R; MacDonald DJ; Blazer KR; Cullinane CA
Arch Surg; 2003 Dec; 138(12):1323-8; discussion 1329. PubMed ID: 14662532
[TBL] [Abstract][Full Text] [Related]
34. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
Schwartz MD; Lerman C; Brogan B; Peshkin BN; Isaacs C; DeMarco T; Halbert CH; Pennanen M; Finch C
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1003-7. PubMed ID: 15824179
[TBL] [Abstract][Full Text] [Related]
35. Numerous high-risk epithelial lesions in familial breast cancer.
Hoogerbrugge N; Bult P; Bonenkamp JJ; Ligtenberg MJ; Kiemeney LA; de Hullu JA; Boetes C; Niermeijer MF; Brunner HG
Eur J Cancer; 2006 Oct; 42(15):2492-8. PubMed ID: 16908132
[TBL] [Abstract][Full Text] [Related]
36. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Rebbeck TR; Friebel T; Lynch HT; Neuhausen SL; van 't Veer L; Garber JE; Evans GR; Narod SA; Isaacs C; Matloff E; Daly MB; Olopade OI; Weber BL
J Clin Oncol; 2004 Mar; 22(6):1055-62. PubMed ID: 14981104
[TBL] [Abstract][Full Text] [Related]
37. [Surgical prevention of breast carcinoma in patients with hereditary risk].
Dražan L; Veselý J; Hýža P; Kubek T; Foretová L; Coufal O
Klin Onkol; 2012; 25 Suppl():S78-83. PubMed ID: 22920212
[TBL] [Abstract][Full Text] [Related]
38. Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation.
Litton JK; Westin SN; Ready K; Sun CC; Peterson SK; Meric-Bernstam F; Gonzalez-Angulo AM; Bodurka DC; Lu KH; Hortobagyi GN; Arun BK
Cancer; 2009 Apr; 115(8):1598-604. PubMed ID: 19280625
[TBL] [Abstract][Full Text] [Related]
39. Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers.
van Roosmalen MS; Stalmeier PF; Verhoef LC; Hoekstra-Weebers JE; Oosterwijk JC; Hoogerbrugge N; Moog U; van Daal WA
J Clin Oncol; 2004 Aug; 22(16):3293-301. PubMed ID: 15310772
[TBL] [Abstract][Full Text] [Related]
40. Surgical decisions made by 158 women with hereditary breast cancer aged <50 years.
Evans DG; Lalloo F; Hopwood P; Maurice A; Baildam A; Brain A; Barr L; Howell A
Eur J Surg Oncol; 2005 Dec; 31(10):1112-8. PubMed ID: 16005602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
